Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) FCF Margin (2021 - 2025)

Historic FCF Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 414168.33%.

  • Molecular Partners Ag's FCF Margin fell 43455256500.0% to 414168.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 1176.15%, marking a year-over-year decrease of 51143800.0%. This contributed to the annual value of 1199.06% for FY2024, which is 8346440562000.0% down from last year.
  • Latest data reveals that Molecular Partners Ag reported FCF Margin of 414168.33% as of Q3 2025, which was down 43455256500.0% from 1474.47% recorded in Q1 2025.
  • Molecular Partners Ag's FCF Margin's 5-year high stood at 4759693.98% during Q3 2024, with a 5-year trough of 6399262.18% in Q3 2022.
  • In the last 5 years, Molecular Partners Ag's FCF Margin had a median value of 0.0% in 2021 and averaged 58185.62%.
  • As far as peak fluctuations go, Molecular Partners Ag's FCF Margin tumbled by 2000000000bps in 2022, and later soared by 2000000000bps in 2023.
  • Molecular Partners Ag's FCF Margin (Quarter) stood at 937.65% in 2021, then surged by 107bps to 61.9% in 2022, then plummeted by -1574496bps to 974624.77% in 2023, then skyrocketed by 100bps to 1199.34% in 2024, then surged by 34633bps to 414168.33% in 2025.
  • Its FCF Margin stands at 414168.33% for Q3 2025, versus 1474.47% for Q1 2025 and 1199.34% for Q4 2024.